May Microbiome Modulation. Assaf Oron, CBO Biomed Conference Tel Aviv, May 2017
|
|
- Rebecca Amice Grant
- 6 years ago
- Views:
Transcription
1 May 2017 Microbiome Modulation Assaf Oron, CBO Biomed Conference Tel Aviv, May 2017
2 Microbiome A revolutionary cure Linda, lives in California 2010 Was treated with antibiotics due to a severe urinary tract infection Soon after Tested positive for C. Diff Multiple Antibiotics Flagyl, Vanomycin Vitamin supplements, probiotics I lost 68 pounds in 4 years 2014 Linda underwent Fecal Microbiota Transplantation (FMT) and was cured
3 Microbiome A revolutionary cure
4 Our Microbiome We have > X100 microbial genes than human genes Our Microbiome Microbials (mainly bacteria) that reside in/on our body Human DNA 99.9% identical Microbiome DNA 80-90% identical
5 The Microbiome plays a vital role and interventions are paving a path forward Obesity alters gut microbial ecology Google trends Microbiome Gut Bacteria Shakes up Cancer Research Microbiome Bacterial imbalance in Crohn s disease Microbial cocktails join fecal transplants in IBD
6 Microbiome Can it cure obesity? Microbiota Transplant Microbiota Transplant
7 Microbiome Industry License to C. Diff. Phase II candidate and other - $120M upfront + $660M MS + Royl. Vedanta license IBD Pre-clinical product to Janssen
8 BiomX Mission We develop novel therapeutics to alleviate microbiome-related diseases using our 3-tier Microbiome Modulation Platform, devised by world-leading scientists
9 BiomX at a Glance Establishment Founded 2015 Based in Israel >20 Employees Investors Pipeline P. acnes Pre-Clinical IBD Pre-Clinical GI tract associated Cancers Phage Discovery Immune oncology Target Discovery Technology Our 3-Tier Microbiome Modulation Platform: Target Bacteria Discovery Microbiome Modulation Drug Development Scientific Founders Prof. Rotem Sorek, Weizmann Institute - Expert in phage biology Dr. Expert in phage biology, Leader in microbiome research Prof. Timothy K, Lu, MIT - Leader in phage engineering therapeutics Financing Completed $24 M series A
10 Groundbreaking research from BiomX founders has unlocked a Broad microbiome drug potential Dr. Eran Elinav MD, PhD Developed unique mouse models and humanized mice World leader in microbiome research Published in Cell, Science Prof. Timothy K. Lu MD, PhD Extensive work with engineered bacteriophage therapeutics for antibiotic-resistant infection World leader in synthetic biology Published in Nature, Science Prof. Rotem Sorek PhD Expert in phage biology and massive genome analyses World leader in CRISPR research Published in Nature, Science
11 Our 3-Tier Microbiome Modulation Platform Target Bacteria Discovery Microbiome Modulation Product Development
12 Target bacteria discovery Target Bacteria Discovery 100 trillion bacteria
13 Target bacteria discovery Target Bacteria Discovery >1,000 species
14 Target bacteria discovery Target Bacteria Discovery 10,000 s strains
15 Target bacteria discovery Target Bacteria Discovery Add Stimuli
16 Target bacteria discovery Target Bacteria Discovery X
17 Target bacteria discovery Eradicate Phage Discovery Microbiome Modulation X A proprietary high throughput platform for natural and synthetic phage discovery
18 Bacteriophage cocktails as therapeutic agent 1 LOCATE 2 INJECT 3 INFECT Viral Genome 4 MULTIPLY 5 ASSEMBLE 6 A BACTERIOPHAGE IS A VIRUS THAT INFECTS ONLY A SPACIFIC BACTERIUM 3 Tail Fiber 6 ERADICATE 7 SEEK 5 4
19 Target bacteria discovery Eradicate Phage Discovery Microbiome Modulation X A proprietary high throughput platform for natural and synthetic phage discovery Add Bacteria Culturing, stability, reproducibility
20 Target bacteria discovery Product Development In Vivo testing Advanced In-Vitro/Ex-Vivo testing Process development Formulation Production Regulatory Phage formulation in collaboration with Takeda BX001 spray dried Dissolution Formulation Dissolution
21 End-to-end Microbiome Modulation Platform Target Bacteria Discovery Microbiome Modulation Product Development
22 A broad & diverse pipeline Step 1 TARGET DISCOVERY Step 2 MICROBIOME MODULATION Step 3 PRE-CLINICAL DEVELOPMENT Step 4 CLINICAL DEVELOPMENT ACNE BX001 IBD (INFLAMMATORY BOWEL DISEASE) BX002 GI associated Cancers Harnessing Synthetic Biology IMMUNO-ONCOLOGY Checkpoint Inhibitors
23 Acne BX001 $5.1B Acne Therapy Market A topical gel of a proprietary phage cocktail BX001 on a lawn of P. acnes 1 2 Target what s needed, not damaging good bacteria Address antibiotic resistance An opportunity for novel alternatives to antibiotics 3 Black Where gel with BX001 was applied Red Area of phage activity (eradicated P.acnes) Self replicating Increased activity in site * 2017 total acne therapy market forecast, Acne Treatment Market: Global Industry Analysis and Forecast, , Persistence Market Research
24 Density (OD 600nm) IBD BX002 $8B IBD therapy market A phage cocktail eradicating IBD inducing bacteria Clear evidence that gut bacteria impacts IBD BX002 eradicated specific IBD inducing bacteria Time (Hrs) Red Control, only bacteria Green Bacteria + BX002 Bacteria eradicated: 1 2 Novel, specific IBD induction path Demonstrate IBD induction in-vivo 3 Antibiotic resistant * CCFA Crohn s & Colitis Foundation of America. Visiongain IBD report
25 May 2017 Thank You! Visit us at
SYMBIOTIC HEALTH. Targeted GI Delivery of Orally Administered Cells and Proteins for Microbiome-Based Therapeutics
SYMBIOTIC HEALTH Targeted GI Delivery of Orally Administered Cells and Proteins for Microbiome-Based Therapeutics Contact: Gerard Honig PhD, Director ghonig@symbioticbio.com Overview Biotechnology startup
More informationAssembly Biosciences Jefferies 2015 Microbiome Summit. December 16, 2015
Assembly Biosciences Jefferies 2015 Microbiome Summit December 16, 2015 Forward-Looking Statements This presentation contains forward-looking statements regarding future events. Forward-looking statements
More informationAn introduction into 16S rrna gene sequencing analysis. Stefan Boers
An introduction into 16S rrna gene sequencing analysis Stefan Boers Microbiome, microbiota or metagenomics? Microbiome The entire habitat, including the microorganisms, their genomes (i.e., genes) and
More informationREIMAGINING DRUG DEVELOPMENT:
Biology Reconstructed REIMAGINING DRUG DEVELOPMENT: Accurate Disease Modeling To Drive Successful Therapies Julia Kirshner, CEO julia@zpredicta.com 1 SUCCESS RATES OF DRUG DEVELOPMENT ARE LOW, " PARTICULARLY
More informationUBS 2016 Health Care Conference May 24, 2016
Leading the Microbiome Revolution UBS 2016 Health Care Conference May 24, 2016 Forward Looking Statements Some of the statements in this presentation constitute forward looking statements under the Private
More informationCHAPTER 2A HOW DO YOU BEGIN TO CLONE A GENE? CHAPTER 2A STUDENT GUIDE 2013 Amgen Foundation. All rights reserved.
CHAPTER 2A HOW DO YOU BEGIN TO CLONE A GENE? 35 INTRODUCTION In the Program Introduction, you learned that the increase in diabetes in the United States has resulted in a great demand for its treatment,
More informationNanotechnology: A Brief History and Its Convergence with Medicine. Weston Daniel, PhD Director of Program Management
Nanotechnology: A Brief History and Its Convergence with Medicine Weston Daniel, PhD Director of Program Management Outline Introduction The Nanoscale Applications Realization of a Vision There s Plenty
More informationPhage therapy. Institute of Molecular Biomedicine Comenius University, Faculty of Medicine
Phage therapy Institute of Molecular Biomedicine Comenius University, Faculty of Medicine www.imbm.sk tothova.lubomira@gmail.com Outline Introduction Taxonomy Cycles of phages Bacterial resistance Phage
More informationCarl Woese. Used 16S rrna to developed a method to Identify any bacterium, and discovered a novel domain of life
METAGENOMICS Carl Woese Used 16S rrna to developed a method to Identify any bacterium, and discovered a novel domain of life His amazing discovery, coupled with his solitary behaviour, made many contemporary
More informationGrowing Together: How Viruses Have Shaped Human Evolution. Shirlee Wohl Katherine Wu
Growing Together: How Viruses Have Shaped Human Evolution Shirlee Wohl Katherine Wu What comes to your mind when you hear the word virus? flu public health cold vaccine infection disease cough biology
More informationEtienne Ruppé AP HP, Hôpital Bichat Claude Bernard UMR 1137 IAME
Etienne Ruppé AP HP, Hôpital Bichat Claude Bernard UMR 1137 IAME Disclosures Consultant for DaVolterra and MaaT Pharma Received funds by biomérieux 2 1. The intestinal microbiota 3 16S profiling 16S and
More informationDNA: THE GENETIC MATERIAL
DNA: THE GENETIC MATERIAL This document is licensed under the Attribution-NonCommercial-ShareAlike 2.5 Italy license, available at http://creativecommons.org/licenses/by-nc-sa/2.5/it/ 1. Which macromolecule
More informationleading the way in research & development
leading the way in research & development people. passion. possibilities. ABBVIE 2 immunology AbbVie Immunology has a demonstrated record of success in identifying and developing both small molecule and
More informationChapter 18. Viral Genetics. AP Biology
Chapter 18. Viral Genetics AP Biology What is a virus? Is it alive? DNA or RNA enclosed in a protein coat Viruses are not cells Extremely tiny electron microscope size smaller than ribosomes ~20 50 nm
More informationFirst-in-Class Bispecific Antibodies For Cancer Immunotherapy
First-in-Class Bispecific Antibodies For Cancer Immunotherapy 2015 Company Highlights Vision Team Platform Pipeline Partners To dominate the bispecific antibody space in immunooncology through unique pipeline
More information2054, Chap. 13, page 1
2054, Chap. 13, page 1 I. Microbial Recombination and Plasmids (Chapter 13) A. recombination = process of combining genetic material from 2 organisms to produce a genotype different from either parent
More informationCourse Descriptions. BIOL: Biology. MICB: Microbiology. [1]
Course Descriptions BIOL: Biology http://www.calendar.ubc.ca/vancouver/courses.cfm?code=biol [1] BIOL 112 (3) Biology of the Cell The principles of cellular and molecular biology using bacterial and eukaryotic
More informationInvestor Presentation November 2017
Investor Presentation November 2017 1 DISCLAIMER The material contained in this document is a presentation of general information about the proposed activities of Microba Pty Ltd as at the date of this
More information+ + + MALARIA HIV/AIDS TUBERCULOSIS LEISHMANIASIS CHAGAS DISEASE DENGUE EBOLA ZIKA
At the Center for Infectious Disease Research, we use systems biology approaches and cutting-edge technologies to accelerate the development of life-saving drugs, diagnostics and treatments for the world
More informationRebiotix: Business, Regulatory and Clinical Challenges in Commercializing a Microbiota Based Drug. May 2016
Rebiotix: Business, Regulatory and Clinical Challenges in Commercializing a Microbiota Based Drug May 2016 Rebiotix Pioneer in Microbiome Therapeutics Privately held clinical stage biotechnology company
More informationTopical sirna for management of androgenic alopecia and oily skin Quark Pharmaceuticals, Inc.
Topical sirna for management of androgenic alopecia and oily skin 1 2017 Quark Pharmaceuticals, Inc. About Quark Founded in 1993; privately held Late stage pharmaceutical company with 2 Phase 3 programs,
More informationShaw Nielsen Shaw Nielsen. 16 Harvard Public Health
Shaw Nielsen Shaw Nielsen 16 Harvard Public Health tthe story of public health has largely been a story of conquering infections, from smallpox to syphilis to scarlet fever. Since the late 19th century,
More informationMetagenomic Analysis in Human- Associated Projects
Metagenomic Analysis in Human- Associated Projects Wikimedia Commons Wikimedia Commons Daniel H. Huson Singapore Center for Environmental Life Science Engineering (SCELSE) ZBIT Center for Bioinformatics
More informationViruses 11/30/2015. Chapter 19. Key Concepts in Chapter 19
Chapter 19 Viruses Dr. Wendy Sera Houston Community College Biology 1406 Key Concepts in Chapter 19 1. A virus consists of a nucleic acid surrounded by a protein coat. 2. Viruses replicate only in host
More informationMarie Skłodowska-Curie European Fellowship
Marie Skłodowska-Curie European Fellowship Expression of Interest Application Form 2017 This form must be completed for Expressions of Interest (EoIs) to the Marie Skłodowska-Curie European Fellowship
More informationConference call transcript for the March 2017 Quarterly Report
ASX ANNOUNCEMENT Conference call transcript for the March 2017 Quarterly Report Sydney Australia, 31 May 2017: Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today lodged its transcript
More informationRoche in Australia Innovation Leader
Roche in Australia Innovation Leader About Roche Innovation: it s in our DNA 7,000,874 hours of work 6,587 experiments 423 researchers 1 drug For nearly 120 years, Roche has been committed to improving
More informationName(s): Period: Date:
Carrying Capacity and Foodborne Illness HASPI Medical Biology Lab 09b Background Microflora of the Intestinal Tract Ecosystems have carrying capacities, which are limits to the numbers of organisms and
More informationBL-7040: Oligonucleotide for Inflammatory Bowel Disease
BL-7040: Oligonucleotide for Inflammatory Bowel Disease December 2012 Forward Looking Statements This presentation contains "forward-looking statements." These statements include words like "may," "expects,"
More informationDrug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research
Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research Drug Development Process by which new chemical entities
More informationTransduction of an Antibiotic Resistance Gene. Background
I Student Guide 21-1128 Name------------ Date Transduction of an Antibiotic Resistance Gene Background Transduction is a natural method of gene transfer that occurs in bacteria. The key player in transduction
More informationTargeting Phage & Antibiotic Resistance 2018 May 17-18, 2018 Page 2
Targeting Phage & Antibiotic Resistance 2018 May 17-18, 2018 Page 2 Day 1 May 17, 2018 7h30 8h55 Registration & welcoming of attendees Badges & Abstracts book Distribution Opening Ceremony 9h00 General
More informationWorking together for better health. Partnering with Boehringer Ingelheim
Working together for better health Partnering with Boehringer Ingelheim Welcome to Boehringer Ingelheim Partnering Our vision Value through innovation is a reality A demonstrable history of innovation
More informationPreservation and Skin Microflora: A Conflict? Understanding the Role of Skin Microflora in Cosmetic Formulation
Preservation and Skin Microflora: A Conflict? Understanding the Role of Skin Microflora in Cosmetic Formulation Importance of the Skin Microbiome Introduction Skin microbiome discovery is a revolutionary
More informationADVANCING SCIENTIFIC INNOVATION Together, the possibilities are endless.
ADVANCING SCIENTIFIC INNOVATION Together, the possibilities are endless. COMMUNICATE INNOVATE EXPLORE COLLABORATE PARTNERSHIPS THAT BENEFIT YOU, US, AND ALL OF MANKIND Since Eli Lilly and Company was founded
More informationINTELLIGENT ANTIBODY DISCOVERY FROM HUMANS AND OTHER ANIMALS. Guy Cavet
INTELLIGENT ANTIBODY DISCOVERY FROM HUMANS AND OTHER ANIMALS Guy Cavet g.cavet@atreca.com PRECISION THERAPIES FROM THE ACTIVE IMMUNE RESPONSE Patient/Animal with Immune Response Immune Repertoire Capture
More informationBiosafety and the NIH Guidelines
Biosafety and the NIH Guidelines This section will explore: Why the NIH Guidelines are important The definition of recombinant or synthetic nucleic acid research Content of the NIH Guidelines Section III
More informationMicrobial Biotechnology agustin krisna wardani
Microbial Biotechnology agustin krisna wardani 1. The Structure of Microbes Microbes (microorganisms) are tiny organisms that are too small to be seen individually by the naked eye and must be viewed with
More informationHuman-microbe mutualism: stability and resilience in health and disease
Human-microbe mutualism: stability and resilience in health and disease David A. Relman, Stanford University IOM Forum on Microbial Threats March 7, 2012 Our extended self : human-microbe mutualism (Based
More informationDNA is the Genetic Material
Lecture#1 DNA is the Genetic Material Readings: Griffiths et al (2004) 8th Edition: Chap. 1, 2-4; Chap. 7 pp 227-249 Problems: Chap. 7: 1-25, 26, 27 Genetics has been approached from two directions. Mendel,
More informationDNA The Genetic Material
DNA The Genetic Material 2006-2007 Genes are on chromosomes Morgan s conclusions genes are on chromosomes but is it the protein or the DNA of the chromosomes that are the genes? initially proteins were
More informationHuman Microbiome Project: First Map of the World Within Us. Hsin-Jung Joyce Wu "Microbiota and man: the story about us
Human Microbiome Project: First Map of the World Within Us Immune disorders: The new epidemic Gut microbiota: health and disease Disease Health Human Microbiome Project: The concept of superorganism :
More informationBiotechnology, Synthetic Biology, and Genetic Circuit Design Module Lesson Plan. 1 day. 1 P age
1 P age Biotechnology, Synthetic Biology, and Genetic Circuit Design Module Lesson Plan 1 day 2 P age Introduction In this single module students will build upon their previous knowledge of basic molecular
More informationBIOLOGIC MEDICATIONS IN THE TREATMENT OF IBD. crohnsandcolitis.ca
BIOLOGIC MEDICATIONS IN THE TREATMENT OF IBD crohnsandcolitis.ca BIOLOGIC MEDICATIONS IN THE TREATMENT OF IBD INFLAMMATION AND IMMUNITY IN CROHN S AND COLITIS Inflammation is the body s normal and natural
More informationThe Human Microbiome: A New Paradigm? John Huss Department of Philosophy The University of Akron
The Human Microbiome: A New Paradigm? John Huss Department of Philosophy The University of Akron Structure of talk Some thoughts on the HMP and metagenomics Two paradigms of disease/health Old paradigm:
More informationMICROBIO, IMMUN, PATHOLOGY-MIP (MIP)
Microbio, Immun, Pathology-MIP (MIP) 1 MICROBIO, IMMUN, PATHOLOGY-MIP (MIP) Courses MIP 101 Introduction to Human Disease (GT-SC2) Credits: 3 (3-0-0) Survey of human systems and diseases. Additional Information:
More informationImmune System. Viruses vs. Bacteria
Immune System Viruses vs. Bacteria Concept Map Section 19-1 Bacteria are classified into the kingdoms of Eubacteria Archaebacteria include a variety of lifestyles such as live in harsh environments such
More informationTHE INHERENT CHALLENGES OF TESTING C. DIFFICILE
THE INHERENT CHALLENGES OF TESTING C. DIFFICILE Detecting Toxins Associated with C. difficile Infection Pritty Patel, MS, MBA, Global Director of Microbiology, Vaccines and Novel Immunotherapeutics, Covance
More informationBiotechnology: Genomics: field that compares the entire DNA content of different organisms
Biotechnology: New Terms Today: Genome Genetic engineering, transgenic organisms, GM food, Reproductive and therapeutic cloning Stem cells, plouripotent, totipotent Gene therapy Genomics: field that compares
More informationViruses. Chapter 19. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for
Chapter 19 Viruses PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp Copyright
More informationFDA Perspectives On Viral & Vector Shedding Studies. Daniel Takefman, Ph.D. Chief, Gene Therapy Branch FDA/CBER ICH Workshop: October 31, 2007
FDA Perspectives On Viral & Vector Shedding Studies Daniel Takefman, Ph.D. Chief, Gene Therapy Branch FDA/CBER ICH Workshop: October 31, 2007 Overview Define shedding studies Outline basis for need of
More informationInflammatory Bowel Disease
Inflammatory Bowel Disease ICONplc.com Inflammatory bowel disease (IBD) is a chronic, relapsing, inflammatory disorder of the gastrointestinal tract and includes Ulcerative Colitis (UC) and Crohn s Disease
More informationTreatment: Nutrition and Medication
INFLAMMATORY BOWEL DISEASE (IBD): CROHN S DISEASE Treatment: Nutrition and Medication While there is no cure for Crohn s disease, there are a number of options to help treat it. The goals of treatment
More informationBEAM Alliance urges G20 support to fight deadly superbugs
Press Release BEAM Alliance urges G20 support to fight deadly superbugs At the Hamburg G20 summit, political leaders will speak about a growing global health threat - antibiotic resistance - which causes
More information15.3 Applications of Genetic Engineering
15.3 Applications of Genetic Engineering Agriculture and Industry Almost everything we eat and much of what we wear come from living organisms. Researchers have used genetic engineering to try to improve
More informationRegulatory Pathways for Rare Diseases
Regulatory Pathways for Rare Diseases Celia M. Witten, Ph.D., M.D. Deputy Director, FDA Center for Biologics Evaluation and Research Emerging Technologies for Rare Diseases: Clinical and Regulatory Case
More informationLTX 109. BIO International Philadelphia 2015
LTX 109 BIO International Philadelphia 2015 Lytix Biopharma company background Established in 2003 to develop and commercialize medical applications of lytic peptides originating from the University of
More informationIntroduction to Bioinformatics
Introduction to Bioinformatics Alla L Lapidus, Ph.D. SPbSU St. Petersburg Term Bioinformatics Term Bioinformatics was invented by Paulien Hogeweg (Полина Хогевег) and Ben Hesper in 1970 as "the study of
More informationSCORE (Sewage biomarker analysis for community health assessment) COST Action No. ES1307
SCORE (Sewage biomarker analysis for community health assessment) COST Action No. ES1307 Minutes of the Working Group 2 (subgroup: pathogens) Meeting, held in Kraków, Poland, 10-12 February 2016. Attendees
More informationViruses. Chapter 19. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for
Chapter 19 Viruses PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp Copyright
More informationMice as Translational Models: Planning a Fecal Microbiota Transplantation Study
Mice as Translational Models: Planning a Fecal Microbiota Transplantation Study RANDI LUNDBERG, DVM APPLICATIONS SCIENTIST 3 rd Annual Translational Microbiome Conference Boston, April 11-13, 2017 FMT
More informationGenetic material must be able to:
Genetic material must be able to: Contain the information necessary to construct an entire organism Pass from parent to offspring and from cell to cell during cell division Be accurately copied Account
More informationGlobal Leader in Viral Vector Technologies
Global Leader in Viral Vector Technologies Gene Therapy Vaccines - Discovery 1 SIRION BIOTECH ANY GENE TO ANY CELL Expert for viral vectors Competitive proprietary viral vector platforms High-end enabling
More informationVenture Philanthropy Models: The Leukemia & Lymphoma Society's Therapy Acceleration Program. A FasterCures Webinar June 19, 2013
Venture Philanthropy Models: The Leukemia & Lymphoma Society's Therapy Acceleration Program A FasterCures Webinar June 19, 2013 What is FasterCures? Founded in 2003, our mission is to save lives by saving
More informationSpostiamo ora la nostra attenzione sui batteri, e batteriofagi
Spostiamo ora la nostra attenzione sui batteri, e batteriofagi Bacteria Mutate Spontaneously and Grow at an Exponential Rate. Useful for genetics studies, development of genetic engineering Teoria dell'adattamento
More informationSORRENTO THERAPEUTICS, INC. (Exact Name of Registrant as Specified in its Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event
More informationIntroducing new DNA into the genome requires cloning the donor sequence, delivery of the cloned DNA into the cell, and integration into the genome.
Key Terms Chapter 32: Genetic Engineering Cloning describes propagation of a DNA sequence by incorporating it into a hybrid construct that can be replicated in a host cell. A cloning vector is a plasmid
More informationAxel Hoos, M.D., Ph.D., SVP, Therapeutic Area Head for Oncology R&D and Head of Immuno Oncology, GSK
Magazine Article September 1, 2016 Source: Life Science Leader By Rob Wright, Chief Editor, Life Science Leader Follow Me On Twitter @RfwrightLSL Is Oncology Back At GSK? Did It Ever Leave? Axel Hoos,
More informationINNOVATION ALMOST 180 MILLION EUROS AREAS OF INNOVATION
From health to beauty INNOVATION IMAGINING FUTURE PRODUCTS 40 Investments in R&D reflect the importance that we attach to the discovery and development of innovative therapeutic and well-being solutions,
More informationTHE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA. themmrf.org
THE PATH TO PRECISION MEDICINE IN MULTIPLE MYELOMA themmrf.org ABOUT THE MULTIPLE MYELOMA RESEARCH FOUNDATION The Multiple Myeloma Research Foundation (MMRF) was established in 1998 by identical twin sisters
More informationBiology Test Review Microorganisms
Name: Period: Biology Test Review Microorganisms Use your booklet, notes, & quizzes to complete this review. 1. Define the following terms using a few key words: a. Host cell - victim of the virus b. Retrovirus
More informationCHAPTER 21. Genetic engineering. What is Genetic Engineering? How is genetic engineering used? What are plasmids? DNA Technology Genomics.
CHAPTER 21 DNA Technology Genomics What is Genetic Engineering? Genetic engineering Moving genes from one organism to another Genes can be taken from one organism (plant, animal, virus, or bacteria) and
More information-Immune phenotype -Cancer xenografts -Immune system humanization -Services
-Immune phenotype -Cancer xenografts -Immune system humanization -Services services@herabiolabs.com 859-414-0648 About Hera BioLabs Precision Toxicology & Efficacy: utilizing precisely gene-edited models
More informationRecombinant Antibody Production in Therapeutic Antibody Projects. Keshav Vasanthavada Senior Marketing Specialist, GenScript April 7, 2016
Recombinant Antibody Production in Therapeutic Antibody Projects Keshav Vasanthavada Senior Marketing Specialist, GenScript April 7, 2016 Presentation Outline 1 2 3 4 5 Introduction Recombinant Ab Production
More informationExam MOL3007 Functional Genomics
Faculty of Medicine Department of Cancer Research and Molecular Medicine Exam MOL3007 Functional Genomics Tuesday May 29 th 9.00-13.00 ECTS credits: 7.5 Number of pages (included front-page): 5 Supporting
More informationThe Vaxonella Platform for Oral Recombinant Vaccine Delivery
The Vaxonella Platform for Oral Recombinant Vaccine Delivery Dr Rocky Cranenburgh Chief Scientific Officer Friday 26 th September 2014 4 th International Conference on Vaccines & Vaccination, Valencia
More informationHorizon 2020 Health Summit-IIS La Fe. Valencia, 12 de diciembre de 2017
Horizon 2020 Health Summit-IIS La Fe Valencia, 12 de diciembre de 2017 2 History 3 AsphaTeam +75 members Consultants with Life Science Background 20 team members with PhD High knowhow in drug development
More informationChapter 8 Recombinant DNA Technology. 10/1/ MDufilho
Chapter 8 Recombinant DNA Technology 10/1/2017 1 MDufilho The Role of Recombinant DNA Technology in Biotechnology Biotechnology? Recombinant deoxyribonucleic acid (DNA) technology Intentionally modifying
More informationStem Cell Services. Driving Innovation for Stem Cell Researchers
Driving Innovation for Stem Cell Researchers Stem Cell Services Partner with us and have access to the most advanced and comprehensive stem cell services available today. 675 W. Kendall St. Cambridge,
More informationRegulation of Microbiota- Based Products
Regulation of Microbiota- Based Products LCDR Matthew Steele, PhD Team Leader, Regulatory Review Branch 1 Division of Vaccines and Related Products Applications CBER/OVRR My presentation is an informal
More informationsirna Overview and Technical Tips
1 sirna Overview and Technical Tips 2 CONTENTS 3 4 5 7 8 10 11 13 14 18 19 20 21 Introduction Applications How Does It Work? Handy Tips Troubleshooting Conclusions Further References Contact Us 3 INTRODUCTION
More informationMicrobial allies in Disease Detection and Treatment. Journal club presentation Vijay Chandrasekar
Microbial allies in Disease Detection and Treatment Journal club presentation Vijay Chandrasekar 16.06.2015 Our inner ecosystem Over 100 TRILLION bacteria (including perhaps a billion or more E.Coli) Individuals
More informationDISCOVERY AND VALIDATION OF TARGETS AND BIOMARKERS BY MASS SPECTROMETRY-BASED PROTEOMICS. September, 2011
DISCOVERY AND VALIDATION OF TARGETS AND BIOMARKERS BY MASS SPECTROMETRY-BASED PROTEOMICS September, 2011 1 CAPRION PROTEOMICS Leading proteomics-based service provider - Biomarker and target discovery
More informationBrief History. Many people contributed to our understanding of DNA
DNA (Ch. 12) Brief History Many people contributed to our understanding of DNA T.H. Morgan (1908) Frederick Griffith (1928) Avery, McCarty & MacLeod (1944) Erwin Chargaff (1947) Hershey & Chase (1952)
More informationGenomics. Genomics. Understanding the human genome. The human genome. Genomics = study of an organism s entire genome or entire DNA sequence
Genomics Genomics Genomics = study of an organism s entire genome or entire DNA sequence billion bases % of DNA shared Humans 3.2 99.5% Chimpanzee 2.8 98.5% Mouse 2.5 80% Chicken 1.0 So what s a genome?
More informationChapter 18 Review Page 1
hapter 18 Review Page 1 1 In this diagram of a virus, the pointer is indicating the virus's capsid. genome. envelope. mitochondria. microfilaments. 2 Viral N makes mrn by the process of lysis. infection.
More informationBiotechnology: Unlocking Nature s Secrets
Course Syllabus Biotechnology: Unlocking Nature s Secrets Course Code: EDL052 Course Description How is technology changing the way we live? Is it possible nature can provide all the answers to some of
More informationPharmacy Benefit Drug Trends and Pipeline. Casey Robinson, PharmD, MBA, Cigna Pharmacy Management
Pharmacy Benefit Drug Trends and Pipeline Casey Robinson, PharmD, MBA, Cigna Pharmacy Management Disclosure and Conflict of Interest Dr. Robinson declares no conflicts of interest, real or apparent, and
More informationIMPACT OF DIET ON MICROBIOTA COMPOSITION AND FUNCTION IN THE SMALL INTESTINE Microbiome Drug Development Summit
IMPACT OF DIET ON MICROBIOTA COMPOSITION AND FUNCTION IN THE SMALL INTESTINE Microbiome Drug Development Summit 2017 29-06-2017 Els van Hoffen Senior scientist and project manager Nutrition & Health els.vanhoffen@nizo.com
More informationCorporate Presentation. March 2018
Corporate Presentation March 2018 Forward Looking Statements This presentation contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation
More informationMoving Forward: Advantages and Challenges of Closed-Loop Control for Cell-Based Therapies
Moving Forward: Advantages and Challenges of Closed-Loop Control for Cell-Based Therapies Guy-Bart Stan Control Engineering Synthetic Biology Group Centre for Synthetic Biology and Innovation Department
More informationCellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) - Pipeline Review, H1 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Cellular Tumor Antigen P53 (Tumor Suppressor P53 or Antigen NY-CO-13) - Pipeline Review, H1 2016 Cellular Tumor
More informationPatentability/Literature Research
Patentability/Literature Research The probiotic-based solution to combat cholera as presented here comprises of two major innovative components: (1) the metabolite-dependent pathogen inhibition by a probiotic
More informationA unique Collaborative Model for the Discovery of New Therapeutic Approaches
A unique Collaborative Model for the Discovery of New Therapeutic Approaches THE INNOVATION GAP OPEN INNOVATION TO ADDRESS THE LACK OF PRODUCTIVITY OF BIOPHARMACEUTICAL RESEARCH A PRE-COMPETITIVE PHARMA
More informationChapter 13 Active Reading Guide The Molecular Basis of Inheritance
Name: AP Biology Mr. Croft Chapter 13 Active Reading Guide The Molecular Basis of Inheritance Section 1 1. What are the two chemical components of chromosomes? 2. Why did researchers originally think that
More information